Los Angeles Business Journal

LA HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Gymnasium Muscles Into Kids’ Market

Cave CrossFit looks to make play with new program for children.Cave CrossFit works out a plan for a new kids’ program.

By Subrina Hudson April 14, 2014 midnight   $$ Share

Earnings Roundup: Avery, Cheesecake, IPC, Teledyne, On Assignment

A slimmer Avery Dennison Corp. on Wednesday announced fiscal first quarter results that were in line with Wall Street expectations for profit. Cheesecake Factory Inc. said Wednesday that same-store sales rose at most of its outlets during the fiscal first quarter but poor weather cut into profits. IPC disappoints. Defense cuts hit Teledyne. On Assignment meets forecasts.

Amgen Misses Expectations

Amgen Inc. on Tuesday reported a lower-than-expected first quarter profit, but said it plans to submit its experimental cholesterol drug for approval by the end of the year.

Amgen Drug Wins Fast-Track Status

The U.S. Food and Drug Administration has granted fast-track designation for ivabradine, a heart drug licensed for sale by Amgen Inc. in Thousand Oaks.

Illinois Officials Investigating Herbalife

The Illinois Attorney General’s Office on Thursday said that it is investigating allegations that Herbalife is running a pyramid scheme.

BlackBerry to Collaborate with NantHealth

Smartphone maker BlackBerry announced Tuesday that it has invested in Dr. Patrick Soon-Shiong’s NantHealth with the hope that its smartphones can be married to the West L.A. billionaire’s next-generation medical information technology.

Herbalife Drops on Report of Criminal Probes

A report that both the U.S. Department of Justice and the FBI are investigating Herbalife sent shares of the nutritional supplement company sliding 14 percent on Friday.

Providence Saint Joseph Completes MRI Test

Providence Saint Joseph Medical Center announced it is the first hospital in the nation to conduct an MRI scan of a patient with a new MRI-compatible heart pacemaker.

SEC Halts Trading of GrowLife Shares

Trading in shares of GrowLife Inc. was halted Thursday for two weeks after the Securities and Exchange Commission questioned some of the company’s stock transactions.

Puma Falls on Cancer Drug Data

Shares of Puma Biotechnology Inc. dropped 18 percent on Monday after the Westwood drug developer reported clinical trial results for its experimental breast cancer drug that were less dramatic than investors expected.

MannKind Shares Fall on FDA Delay

Shares of MannKind Corp. fell nearly 8 percent Monday after the company announced that the FDA’s final decision on its inhalable insulin could be delayed beyond an expected April 15 deadline.

Tease photo

Healthy Votes of Approval for Inhalable Insulin

BIOTECH: MannKind stock rises after its device receives FDA panel’s OK.

Shares of MannKind climb after its inhalable insulin device receives FDA panel’s approval.

Amgen Cancer Drug Results Disappoint

Shares of Amgen Inc. fell 4 percent on Friday after the Thousand Oaks biotech giant said an experimental skin cancer drug had not significantly improved survival rates in clinical trial patients although it reduced the size of tumors.

Amgen Ends GlaxoSmithKline Partnership

Amgen Inc. on Thursday said it would pay GlaxoSmithKline more than $275 million to get out of a co-marketing agreement with the British drug company to promote Amgen’s osteoporosis drug Prolia in certain regions outside the United States.

Response Genetics Adds More Health Plans to Client List

Shares of Response Genetics Inc. jumped 18 percent on Thursday after the cancer diagnostic test company signed agreements with six additional health plans and two large health care groups.

FDA Panel Recommends Approval of MannKind's Afrezza

MannKind Corp.'s share price more than doubled in after-hours trading Tuesday, following news that an FDA advisory panel had finally recommended approval of the Valencia company's Afrezza insulin inhaler.